Emily Bergsland
Director, Center for Neuroendocrine Tumors · UCSF Health - Family Medicine Lakeshore
Credentials: · · ·
History
PresentCenter for Neuroendocrine Tumors · UCSF Health - Family Medicine Lakeshore
- Present
UCSF Center for Neuroendocrine Tumors · Stanford Health Care
- 1993–1995
Medical Oncology
- 1991–1992
University of California UCSF
- 1989–1991
UCSF Medical Center House Staff
- 1985–1989
Research
Journal of Clinical Oncology · 2003 · Last of 8 authors · 1,359 citations
Journal of Clinical Investigation · 2003 · 1,084 citations
Systematic review or meta-analysis · Journal of the National Cancer Institute · 2007 · 745 citations
30 papers
28 papers
26 papers · 2 as a fellow
- JS
23 papers
19 papers
17 papers · 4 as a resident
16 papers
16 papers
Grants
- 1999–2028
National Cancer Institute · P30
Project lead · $2M · University of California, San Francisco
- 2021–2027
UCSF Paul Calabresi K12 Career Development Program in Clinical Oncology
National Cancer Institute · K12
Contact PI · $2.6M · University of California, San Francisco
- 2004–2006
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $4.7K · University of California, San Francisco
Clinical trials
- 2023–2028
Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors
Principal investigator · Recruiting · Phase 2
University of California, San Francisco
- 2023–2026
Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms
Principal investigator · Recruiting
University of California, San Francisco
- 2017–2021
Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas
Principal investigator · Completed · Phase 2
University of California, San Francisco
- 2013–2026
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)